Tim Martin

Tim Martin, Vice President of Product at Yseop, specializes in AI-driven solutions for clinical documentation. He discusses how AI is revolutionizing regulatory submissions, drastically cutting document creation times by over 70%. This transformation not only accelerates drug approval processes but also brings significant cost savings for pharma companies. Tim highlights the importance of human oversight in automation and how tools like Veeva are enhancing document workflows. Insights on future skills needed in medical writing are also explored, providing valuable knowledge for industry professionals.